research use only

Lactate

Cat.No.E4473

Lactate (Lactic acid) is the product of glycolysis, produced due to lack of oxygen in contracting skeletal muscle in vivo, and can be utilised under fully aerobic conditions. It plays a key role as a metabolic intermediate and can be used as hemodynamic marker and resuscitation endpoint in several cohorts of critically ill patients.
Lactate Chemical Structure

Chemical Structure

Molecular Weight: 90.08

Quality Control

Chemical Information, Storage & Stability

Molecular Weight 90.08 Formula

C3H6O3

Storage (From the date of receipt) 2 years  -20°C  liquid
CAS No. 50-21-5 Download SDF Storage of Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT05731050 Not yet recruiting
PNH - Paroxysmal Nocturnal Hemoglobinuria
NovelMed Therapeutics
June 2025 Phase 2
NCT05646563 Not yet recruiting
Paroxysmal Nocturnal Hemoglobinuria
NovelMed Therapeutics
March 2025 Phase 2
NCT05036122 Not yet recruiting
Healthy
Mayo Clinic
February 2025 Not Applicable
NCT06384469 Not yet recruiting
Rhinoplasty|Nasal Skin-soft Tissue Envelope Metabolism|Lactic Acid|Autologous Cartilage Grafting
University Hospital Sestre Milosrdnice
January 2 2025 --
NCT05646524 Not yet recruiting
Paroxysmal Nocturnal Hemoglobinuria
NovelMed Therapeutics
January 2025 Phase 2
NCT02785224 Not yet recruiting
Cardiac Arrest
University of Athens|University of Thessaly
December 2024 --

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.